OTONOMY
Otonomy is an expert in the otology field in order to build the premier company dedicated to the treatment of otic disorders via localized drug delivery. This approach has already been widely adopted for the delivery of short-acting antibiotics to treat otitis media through a tympanostomy tube. In addition, otolaryngologists have demonstrated that the injection of steroids into the middle ear cavity can provide a therapeutic effect for patients with acute inner ear disorders such as Ménière’... s disease and sudden sensorineural hearing loss. Expansion of this effort holds great promise for the treatment of chronic hearing loss, severe vertigo, and even tinnitus. The key to Otonomy's leading position in this nascent field is the development of a proprietary formulation platform that provides sustained drug exposure from a single administration. Broad application of this technology has already been established across a number of therapeutic classes, and from these, three product candidates have been advanced into development.
OTONOMY
Industry:
Biopharma Biotechnology Health Care
Founded:
2008-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.otonomy.com
Total Employee:
51+
Status:
Active
Contact:
+1 8587687809
Email Addresses:
[email protected]
Total Funding:
458.01 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Font Awesome Domain Not Resolving Mobile Non Scaleable Content Sitelinks Search Box
Similar Organizations
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Epizyme
Epizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.
QRxPharma
QRxPharma is a pharmaceutical company that develops and commercializes pain management and abuse prevention products.
Relypsa
Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.
Vaxcyte
Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
Tetraphase Pharmaceuticals
Tetraphase Pharmaceuticals is a company leveraging a dynamic drug engine targeted at several significant disease categories.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Perceptive Advisors
Perceptive Advisors investment in Series D - Otonomy
Avalon Ventures
Avalon Ventures investment in Series D - Otonomy
TPG Biotech
TPG Biotech investment in Series D - Otonomy
Domain Associates
Domain Associates investment in Series D - Otonomy
RiverVest
RiverVest investment in Series D - Otonomy
Novo Ventures
Novo Ventures investment in Series D - Otonomy
Jennison Associates
Jennison Associates investment in Series D - Otonomy
OrbiMed
OrbiMed investment in Series D - Otonomy
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series D - Otonomy
Federated Investors
Federated Investors investment in Series D - Otonomy
Official Site Inspections
http://www.otonomy.com Semrush global rank: 3.66 M Semrush visits lastest month: 3.85 K
- Host name: 107.139.231.35.bc.googleusercontent.com
- IP address: 35.231.139.107
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
